OncLive | Bringing the Global Oncology Community Together

Geoffrey Y. Ku, MD, discusses data of durvalumab plus tremelimumab in a biomarker-selected patient population and sheds light on the role of immunotherapy in patients with advanced gastric cancer. Read More >>

Sequencing Challenges Emerge in Myeloma as Options Expand

SM-88 May Fill Unmet Need in Pancreatic Cancer

Monoclonal Antibodies Shake Up Myeloma Paradigm

FDA Approves Pembrolizumab/Axitinib Combo for Frontline RCC

FDA Schedules ODAC Meetings for Pexidartinib in TGCT and Quizartinib in AML

View More Stories >>

View Conference Coverage

2019 State of the Science Summit on Hematologic Malignancies in Wisconsin

2019 European Lung Cancer Congress

2019 NCCN Annual Conference

2019 State of the Science Summit on Hematologic Malignancies

2019 SGO Annual Meeting

Dr. Shah on Ongoing Trials in MCL

Dr. Richardson on Treatment Approaches Targeting Mutational Burden in Myeloma

Dr. Mason on Standard Treatment Approaches in Stage III NSCLC

Dr. Powles on FDA Approval of Pembrolizumab Plus Axitinib in Advanced RCC

OncLive houses thousands of videos that provide updates and information.
See more Videos

Precision Medicine in Solid Tumor Malignancies

Selecting an Optimal Second-Line Regimen for mRCC

Frontline Therapy for mRCC: Sequencing and Goals

Evaluating I-O Monotherapy's Value in Treating mRCC

mRCC: Identifying and Managing AEs in TKIs and IO Therapy

CDK4/6 Inhibitors: Treating Beyond Progression

Selecting a CDK4/6 Inhibitor in HR+ Breast Cancer

OncLive houses thousands of videos that provide updates and information.
See more Videos

Standard of Care in Metastatic Prostate Cancer

Real-World Patients With High Risk of MACEs

GnRH Antagonists Versus GnRH Agonists

Effects of ADT on Morbidity and Mortality

Data Supporting the Risk of MACEs in ADT

Pancreatic Cancer: Unmet Needs and Future Directions

Nanoliposomal Irinotecan in Pancreatic Cancer: Managing AEs

OncLive houses thousands of videos that provide updates and information.
See more Videos

Featured

Expert Anticipates Cure in Acute Lymphoblastic Leukemia

Elias Jabbour, MD, discussed recent clinical trial results in acute lymphoblastic leukemia, the role of immunotherapy, and the biggest challenges facing the field.

View more >>>